All Videos

Discover groundbreaking dermatologic therapies and new drug approvals presented at Maui Derm NP+PA Fall, featuring insights from experts George Martin, MD, and Ted Rosen, MD.

Elena Hawryluk, MD, PhD, highlights innovative pediatric dermatology at Maui Derm NP+PA Fall, emphasizing education and advancements in tumor genetics.

Preview the Maui Derm NP+PA Fall 2025 Conference with program director George Martin, MD, featuring cutting-edge education and expert insights in Nashville.

Evidence presented at EADV supports upadacitinib’s long-term use in atopic dermatitis and other inflammatory conditions.

Galvokamig, a biologic targeting IL-13 and IL-17A/F, demonstrated significant benefits in moderate to severe atopic dermatitis.

Panelists discuss the importance of a gentle, minimalist skin care routine tailored to support the skin barrier in sensitive or compromised skin, emphasizing the use of pH-balanced cleansers, barrier-repairing moisturizers, and condition-specific strategies to reduce irritation and promote long-term skin health.

transepidermal water loss as a key indicator of skin barrier integrity, highlighting its relevance in both clinically diagnosed and self-perceived sensitive skin, and emphasizing the importance of barrier-supportive skin care to reduce water loss, promote repair, and manage sensitivity effectively.

Nicole Harter, MD, explores ruxolitinib 1.5% cream for pediatric atopic dermatitis, offering a novel, effective treatment option for children aged 2 to 11.

Nayan Patel, PharmD, reveals how innovative glutathione delivery transforms skin care, combats oxidative stress, and empowers skin health for lasting results.

Discover how Auro GSH by Nayan Patel, PharmD, revolutionizes glutathione delivery in skin care, targeting oxidative stress for healthier skin.

A panelist presents a case of severe, chronic facial seborrheic dermatitis in a young man, highlighting diagnostic challenges and emotional impact, and illustrating how daily use of a phosphodiesterase-4 (PDE4) inhibitor foam led to near-clearance and symptom relief by 8 weeks, underscoring the therapy’s effectiveness, safety, and adaptability to patient preferences.

Panelists discuss the structure and function of the skin barrier, highlighting key components like filaggrin and aquaporins, and emphasizing the need to protect against both environmental and lifestyle-related stressors—collectively known as the exposome—to maintain hydration and support long-term skin health.

Panelists discuss the critical role of maintaining a healthy skin barrier in managing sensitive skin, emphasizing the importance of gentle, evidence-based cleansing and moisturizing practices to prevent irritation, support barrier repair, and improve dermatologic outcomes.

Discover the benefits of RetaXome therapy for sensitive skin and its potential in skin care routines.

Novel formulations like retinal-infused exosomes represent an evolution rather than a replacement of retinoid therapy.

A panelist presents a case of severe seborrheic dermatitis in a young man with facial and scalp involvement, demonstrating how a once-daily, foam-based phosphodiesterase-4 (PDE4) inhibitor provided rapid, complete clearance and itch relief, highlighting the importance of efficacy, cosmetic acceptability, and quality-of-life considerations in treatment selection.

Sofia Wenzler, PhD, highlights the vital role dermatologists play in treating body-focused repetitive behaviors like skin picking and hair pulling.

Vimal Prajapati, MD, FRCPC, DABD, highlighted key findings from the THRIVE-AA trials, noting the efficacy of deuruxolitinib 8 mg BID, its favorable safety profile, and its positioning alongside other JAK inhibitors.

Panelists discuss how evolving concerns about long-term topical corticosteroid use are prompting a shift toward safer, nonsteroidal alternatives such as roflumilast, emphasizing structured treatment plans, early patient education, and improved office workflows to support individualized, steroid-sparing psoriasis care that enhances both outcomes and trust.

Vimal Prajapati, MD, FRCPC, DABD, reviews the mechanism of action, clinical trial outcomes, monitoring considerations, and safety profile of recently available deuruxolitinib.

Sofia Wenzler, PhD, addresses misconceptions about dermatillomania (skin picking) and trichotillomania (hair pulling), advocating for compassionate care and accessible treatment for BFRBs.

A panelist highlights the evolution of seborrheic dermatitis treatment from traditional antifungals and corticosteroids to newer nonsteroidal options such as phosphodiesterase-4 (PDE4) inhibitors, emphasizing the importance of aligning therapy with patient preferences, lifestyle factors, and long-term disease management needs to improve adherence and outcomes.

Renata Block, DMSc, MMS, PA-C, and Isabelle Thibau, MPH, of the National Eczema Association discuss how the EczemaWise app integrates patient-reported outcomes, validated tools, and real-world data to improve collaboration between patients and clinicians in managing eczema.

Discover the latest in regenerative aesthetics and body contouring at DERM 2025, featuring insights from Suneel Chilukuri, MD, on skin care trends and biohacking.

Panelists discuss how the availability of both roflumilast foam and cream allows for personalized, preference-driven treatment plans that enhance adherence while streamlined access strategies and improved topical efficacy are reshaping the role of nonsteroidal agents in psoriasis care, extending their use beyond mild disease to special sites and even as systemic-sparing options.

GLP-1 receptor agonists may indirectly affect dermatologic outcomes by targeting inflammation and metabolic comorbidities.

Members of Elevate-Derm Alliance and the SkinSync podcast discuss the inspiration behind the podcast and how it best serves dermatology clinicians.

Lisa Swanson, MD, FAAD, shares innovative insights on pediatric dermatology, emphasizing effective treatments and communication strategies for young patients at DERM 2025.

An expert discusses how insurance limitations hinder access to newer, more effective acne treatments, emphasizing the need for long-term cost-benefit recognition, while also highlighting the ongoing role of oral antibiotics and the importance of personalized care—especially for adult women with distinct acne profiles.

An expert discusses recent innovations in acne treatment—including the first narrow-spectrum oral antibiotic, an advanced triple-combination topical, and emerging procedural options—highlighting their roles in personalized care, antibiotic stewardship, and achieving long-term therapeutic success.